Streetbeat News

Regulatory

TNXP

Tonix Pharmaceuticals has completed the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL, a potential treatment for fibromyalgia-type long Covid. The topline results are expected to be released in Q3 of 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:24 am

PRAX

Praxis Precision Medicines has announced that an analysis of EEG activity for subjects in their recent Phase 1 study showed pharmacodynamic activity across all dose levels who received PRAX-628 at first administration, compared with subjects who received a placebo.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:20 am

GOGO

Gogo has revised its FY23 revenue guidance to $410M-$420M from $440M-$455M, citing the impact of the Federal Communications Commission's Secure and Trusted Communications Networks Reimbursement Program. The company's long-term revenue target has also been adjusted, with revenue growth expected at a CAGR of 15%-17% from 2022 through 2027, down from the prior target of 17%. Adjusted EBITDA and Free Cash Flow targets remain unchanged.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:09 am

VTRS

The FDA has accepted a new drug application from Viatris and Mapi Pharma for Ga Depot 40 Mg, a once-monthly injection for relapsing forms of multiple sclerosis. The PDUF action date is set for March 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 10:56 am

NRXP

NRx Pharmaceuticals has announced the licensure of a US patent to support the use of NRX-101 for chronic pain. This development could potentially expand the application of NRX-101 beyond its current use.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 10:48 am

NKLA

TSLA

Tesla CEO Elon Musk criticized government funding for hydrogen trucks, calling it 'idiotic' and 'bizarre'. This comes amid discussions surrounding the Hydrogen for Trucks Act, which aims to establish a grant program for heavy-duty fuel cell vehicles powered by hydrogen. Musk has previously expressed skepticism over hydrogen as an efficient fuel source. Meanwhile, Tesla's all-electric heavy-duty semi-truck made its first deliveries to PepsiCo in December last year.

Portfolio Pulse from Anan Ashraf

August 07, 2023 | 10:43 am

SPY

NY Fed President Williams stated that inflation is decreasing as expected and unemployment may rise slightly as the economy cools. He did not dismiss the possibility of lowering rates in early 2024, depending on economic data.

Portfolio Pulse from Charles Gross

August 07, 2023 | 9:17 am

DIS

Disney (NYSE:DIS) and Florida Governor Ron DeSantis continue their feud over the 'Don't say gay' law. DeSantis has allegedly retaliated against Disney's opposition to the law by taking over the Disney World governing district and appointing his nominees to the governing board. This has led to Disney scaling back its investment in Florida and filing a federal lawsuit against DeSantis. The feud has negatively impacted both parties, with Disney's approval rating falling and DeSantis trailing in the Republican presidential primary. Disney's stock was up 0.52% in premarket trading on Monday.

Portfolio Pulse from Shanthi Rexaline

August 07, 2023 | 9:10 am

HSBC

HSBC's head of public affairs, Sir Sherard Cowper-Coles, has apologized for criticizing the UK's compliance with US-China business restrictions. He had previously accused the UK government of being 'weak' for complying with US demands to cut back business dealings with China. These comments were made during a private discussion and were his personal views, not reflecting the views of HSBC or the China-British Business Council.

Portfolio Pulse from Benzinga Neuro

August 07, 2023 | 9:00 am

BIIB

SAGE

Sage Therapeutics and Biogen announced that the FDA has approved ZURZUVAETM 50 Mg for adults with postpartum depression. This approval could potentially boost the companies' revenues and market share in the pharmaceutical industry.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:46 am